Clinical trial
Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally…
NCT00040807 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00040807 |
|---|---|
| Title | Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer |
| Official title | Phase II Trial Of Weekly Irinotecan And Docetaxel In Recurrent Or Metastatic Head And Neck Carcinoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, irinotecan hydrochloride |
| Start date | Nov 19, 2002 |
| Primary completion | Apr 1, 2005 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 18, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: